General Information of Drug (ID: DM3NMPC)

Drug Name
VBI-2601
Indication
Disease Entry ICD 11 Status REF
Hepatitis B virus infection 1E51.0 Phase 2 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DIQ9G6

References

1 ClinicalTrials.gov (NCT04749368) Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic HBV Infection. U.S. National Institutes of Health.